Description: With the rapid development of the Insurance market, insurance technology—including online insurance--continues to mature. Zhongan Online invests heavily in fintechand Zhongan Answer, an insurance robo-advisor, launched in 2018, could improve transaction efficiency by using artificial intelligence to communicate in a timely manner and solve the pain point of the perplexed insurance clause. Under a different consumption scenario, Zhongan Answer could reply to users in a timely manner, while also implementing private customized products and services by providing users with personal risk management and insurance assessment solutions so that users could easily and conveniently select the most suitable insurance plan. The intelligent shopping guide system of Zhongan Answer could improve transaction efficiency by analyzing the personal insurance intention and providing the humanized interpretation of insurance clause. Zhongan Answer has served millions of users and supported more than 100,000 insurance-related knowledge points with an accuracy rate over 90%. Zhongan Answer has provided more than four million Q&A services, and its intelligent shopping guide system covers more than 90% of insurance products.

Description: In the speech, the presenter will share her insights based on three aspects: 1. Investment management is an important part of the whole process of risk management; 2. Methods and processes of asset allocation as well as risk management considerations; 3. The interaction between liability and asset is critical to risk management.

Description: The speaker hopes to share and exchange his own experience and thinking in enterprise management with colleagues in the industry, so as to better solve problems for the enterprise to enhance and expand the value of actuaries themselves.

Description: The April/May 2016 edition of The Actuary magazine—the Society of Actuaries’ flagship publication.

Description: This article discusses how small insurance companies can get into the complex equity indexed market by using alliances wherein there is one primary company and one or more secondary companies. The primary company would perform all of the functions for itself and some of the functions for the secondary companies. The companies pool assets to reach critical mass.

Description: Actuarial funding of OPEB plans is primarily a public sector phenomenon due to the different regulations and tax laws that impact private sector organizations in the US. OPEB funding started to gain momentum with the implementation of GASB Statement 45 in the mid to late 2000s.

Description: Whole life insurance nonforfeiture options may be actuarially equivalent at the time premium payments end. When the entire remaining lifetime of the policy is fully considered; however, significant differences emerge in expenses between paying the cash surrender value, converting to reduced paid-up, or converting to extended term insurance. This article explores how a company might manage its existing nonforfeiture options and consider what to continue to offer after a product refiling with that entire lifetime in mind.

Description: Bell is comparing his roles from that of an actuary in the USA to that of an actuary working in Cameroon, for a pan-African insurance company.

Description: The Supplemental Health, DI & LTC Conference provides a unique opportunity to consider a cross-functional view of supplemental health products, individual disability insurance, and long-term care standalone and combination products.

Description: Explore the value and cost of prescription drugs, how they should be defined and measured and the effects various stakeholders in the pharmacy ecosystem can have on these factors in the latest webcast. You'll investigate the impact of coverage, formulary and rebate negotiations and related benefit design. Find out how actuaries can answer questions related to the prescription drug industry, in addition to improving the access, quality and affordability of prescription drugs in the United States. Join us for this webcast and come learn about value-based contract design, negotiations, implementation and administration for prescription drugs.